Characteristics and Outcomes in Patients with Lenalidomide-Refractory Multiple Myeloma Treated with 1-3 Prior Lines of Therapy: Analysis of Individual Patient-Level Data from Daratumumab Clinical Trials

AuthID
 P-017-ND6
20
Author(s)
Yong, K
·
Schecter, JM
·
Roccia, T
·
Deraedt, W
·
Lendvai, N
·
Slaughter, A
·
Lonardi, C
·
Connors, K
·
Qi, KQ
·
Londhe, A
·
Carson, R
·
Kharat, A
·
Cost, P
·
Valluri, S
·
Mendes, J
·
Pacaud, L
·
Patel, N
·
Florendo, E
·
Dhakal, B
Tipo de Documento
Article
Year published
2025
Publicado
in EUROPEAN JOURNAL OF CANCER, ISSN: 0959-8049
Volume: 215
Indexing
Wos®
Scopus®
Pubmed®
Google Scholar®
Publication Identifiers
Pubmed: 39673835
SCOPUS: 2-s2.0-85211582731
Wos: WOS:001390131800001
Source Identifiers
ISSN: 0959-8049
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Full Text
Full Text @ sfx.b-on.pt

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service